NCT04654702View on ClinicalTrials.gov

Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.

CompletedOBSERVATIONAL
Enrollment

2,671

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

January 10, 2020

Study Completion Date

July 20, 2020

Conditions
Perennial Allergic RhinitisAsthma
Trial Locations (1)

Unknown

59 institutions including Chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY